The sun and New Zealand make for uncomfortable companions. We enjoy largely unpolluted skies and outdoor lifestyles, but at a cost: the country has extremely high rates of skin cancer, one of our most common cancer types. Despite years of warnings about the risks of unprotected exposure to the sun, New Zealand still has a distressingly high rate of melanoma. The deadly skin cancer kills around 270 New Zealanders a year.
A new Queensland study should make policymakers question whether New Zealand is doing enough to prevent skin cancers from claiming so many lives or imposing costs on the health system. The study found that New Zealand melanoma rates have almost doubled over the last three decades - from about 26 cases per 100,000 people in 1982 to about 50 cases per 100,000 in 2011. While Australia's melanoma rates have been declining since 2005, New Zealand's rates are increasing and will not ease - and then only slightly - until next year.
Sadly, for many older, fair-skinned New Zealanders, the damage already has been done. As the country's population ages, the number of melanomas diagnosed will continue to increase, many decades after the cancer-causing exposure to sunlight occurred.
Researchers predict that New Zealand's melanoma rates will be about 46 cases per 100,000 people by 2031. Across the Tasman, rates in sunburnt Australia are expected to keep falling to about 41 cases per 100,000 people by 2031.
Treatment costs individuals and the community, as the push to add the expensive melanoma drug Keytruda to the list of funded medicines has shown. The medical community, however, maintains that skin cancer prevention initiatives are cost effective and an important public health investment.